Results for tag: "Breo Ellipta"

Breo Ellipta is a combination drug used to treat chronic obstructive pulmonary disease (COPD) and asthma. It is a combination of two drugs, fluticasone furoate and vilanterol, which work together to reduce inflammation and open up the airways. Breo Ellipta is a long-acting bronchodilator, meaning it works over a longer period of time than other drugs used to treat respiratory conditions. It is taken once a day, and is available in both an inhaler and a dry powder inhaler. The Breo Ellipta market is a subset of the larger respiratory drugs market. This market is composed of drugs used to treat a variety of respiratory conditions, including COPD, asthma, and other chronic respiratory diseases. These drugs are used to reduce inflammation, open up airways, and improve breathing. Some companies in the Breo Ellipta market include GlaxoSmithKline, AstraZeneca, Merck, and Boehringer Ingelheim. Show Less Read more